HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AKESO

108.700

+2.4002.26%

Volume:16.11M

Turnover:1.72B

Market Cap:100.11B

PE:-88.18

High:109.900

Open:102.100

Low:101.000

Close:106.300

52wk High:156.000

52wk Low:80.200

Shares:921.00M

HK Float Shares:921.00M

Volume Ratio:1.39

T/O Rate:1.75%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.233

ROE:-13.59%

ROA:-4.57%

PB:10.10

PE(LYR):-88.18

PS:24.83

Loading ...

Overview Company News Filings

Akeso (SEHK:9926) Could Be 47% Undervalued As China Approves Ivonescimab Use

Simply Wall St.

Movement Alert｜AKESO Falls 3.09% in Regular Trading, Profit-Taking Continues After Third Indication Approval

Movement Alert｜AKESO Falls 3.49% in Regular Trading, Profit-Taking Continues After Third Indication Approval for Ivonescimab

What Does Akeso (SEHK:9926) China Lung Cancer Approval Mean For Investors?

Simply Wall St.

Movement Alert｜AKESO Falls 3.19% in Regular Trading, Biotech Sector Broadly Under Pressure After Third Indication Approval

Akeso's Ivonescimab Gets Third Indication Approval in China

MT Newswires Live

Movement Alert｜AKESO Rises 3.04% in Regular Trading, Third Indication of Bispecific Antibody Ivonescimab Approved by NMPA

Akeso Says NMPA Approves Ivonescimab for 1L Treatment of SQ-NSCLC

Summit Gains After Partner Akeso Secures China Nod for Lung Cancer Combo

AKESO (09926) Gains NMPA Nod for Third Indication of Its First-in-Class Bispecific Antibody, Ivonescimab, in Frontline Squamous NSCLC

Akeso - Nmpa Approves Ivonescimab for 1L Treatment of Sq-Nsclc

THOMSON REUTERS

Akeso Says China NMPA Approves Ivonescimab Plus Chemo for First-Line Squamous NSCLC

Akeso - China Nmpa Approves Ivonescimab Plus Chemotherapy for First-Line Advanced Squamous Nsclc

THOMSON REUTERS

Akeso (SEHK:9926) Could Be 41% Undervalued On Phase II Breast Cancer Trial Progress

Simply Wall St.

HK Movers | Hong Kong Biotech Stocks Rally; Genscript Bio Jumps Over 7%, Zai Lab Gains Over 6%

Tiger Newspress

Movement Alert｜AKESO Rises 3.15% in Regular Trading, Bispecific ADC Plus Ivonescimab Completes First Patient Dosing in Breast Cancer Phase II Trial

Akeso Doses First Patient in Phase II Trial of Ak146d1 ADC Plus Ivonescimab in Advanced Breast Cancer

Akeso Advances IO2.0 + Adc2.0 Strategy: First Patient Dosed in Phase Ii Study of Trop2/Nectin-4 Bispecific ADC (Ak146d1) Combined with Ivonescimab in Breast Cancer

THOMSON REUTERS

HK Movers | Pharma Stocks Jump With Viva Biotech up 15%, WuXi XDC, WuXi Biologics up 6%

Tiger Newspress

Movement Alert｜AKESO Rises 4% in Regular Trading, Multiple International Registrational Clinical Studies Advancing Rapidly

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/09926/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09926","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09926\",,,,,undefined,":{"symbol":"09926","market":"HK","secType":"STK","nameCN":"AKESO","latestPrice":108.7,"timestamp":1790755707010,"preClose":106.3,"halted":0,"volume":16105342,"delay":0,"changeRate":0.022577610536218304,"floatShares":921000000,"shares":921000000,"eps":-1.232771,"marketStatus":"Not Yet Opened","change":2.4,"latestTime":"09-30 16:08:27","open":102.1,"high":109.9,"low":101,"amount":1720782120,"amplitude":0.083725,"askPrice":108.7,"askSize":40000,"bidPrice":108.6,"bidSize":8000,"shortable":3,"etf":0,"ttmEps":-1.220827,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":0,"adr":0,"listingDate":1587657600000,"exchange":"SEHK","adjPreClose":106.3,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":1.385665612979258,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"AKS.HK","impliedVol":0.0551,"impliedVolPercentile":0.0058},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09926\",,,,,undefined,":{"symbol":"09926","floatShares":921000000,"roa":"-4.57%","roe":"-13.59%","lyrEps":-1.232771,"volumeRatio":1.385665612979258,"shares":921000000,"dividePrice":0,"high":109.9,"amplitude":0.083725,"preClose":106.3,"low":101,"week52Low":80.2,"pbRate":"10.10","psRate":"24.83","week52High":156,"institutionHeld":0,"latestPrice":108.7,"committee":-0.666667,"eps":-1.232771,"divideRate":0,"volume":16105342,"delay":0,"ttmEps":-1.220827,"open":102.1,"prevYearClose":113,"prevWeekClose":93.55,"prevMonthClose":108.7,"prevQuarterClose":108.7,"fiveDayClose":97.5,"twentyDayClose":87.8,"sixtyDayClose":96.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09926\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787794200000,"name":null,"time":"","dateTimestamp":1787760000000,"actualEps":null},{"date":"2026-03-26","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-08-26","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-30","symbol":"09926","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743298200000,"name":null,"time":"Post-Mkt","dateTimestamp":1743264000000,"actualEps":null},{"date":"2024-08-28","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09926\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09926\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.56,"hold":0.04,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.56,"analysts":25,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09926\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09926","date":"2026-09-30","current":-89.038005,"percent":0.223941,"low":-283.614883,"twenty":-99.263335,"median":-26.445589,"eighty":12.991053,"high":20.221708,"avg":-49.07944,"sd":59.169473,"marketCap":100128263231},"quantilePoints":[{"date":"2021-10-08","current":-29.845898,"twenty":-58.976264,"median":-34.085183,"eighty":-24.385279,"marketCap":33499344216},{"date":"2021-10-15","current":-32.807984,"twenty":-58.969537,"median":-33.89682,"eighty":-24.581853,"marketCap":36849278637},{"date":"2021-10-22","current":-33.585285,"twenty":-58.897857,"median":-33.786096,"eighty":-24.856047,"marketCap":37993158684},{"date":"2021-10-29","current":-31.568779,"twenty":-58.531823,"median":-33.627637,"eighty":-25.019036,"marketCap":35623692873},{"date":"2021-11-05","current":-28.336247,"twenty":-58.387259,"median":-33.581277,"eighty":-25.13981,"marketCap":32028641299},{"date":"2021-11-12","current":-31.135474,"twenty":-58.165915,"median":-33.566565,"eighty":-25.305935,"marketCap":35337722862},{"date":"2021-11-19","current":-36.658551,"twenty":-57.747713,"median":-33.576384,"eighty":-25.505551,"marketCap":41547357399},{"date":"2021-11-26","current":-34.737009,"twenty":-57.465203,"median":-33.61015,"eighty":-25.671516,"marketCap":39382155883},{"date":"2021-12-03","current":-31.939354,"twenty":-57.376977,"median":-33.627637,"eighty":-26.141756,"marketCap":36277338614},{"date":"2021-12-10","current":-30.771813,"twenty":-57.264113,"median":-33.577269,"eighty":-26.43668,"marketCap":35010899991},{"date":"2021-12-17","current":-26.05017,"twenty":-56.996271,"median":-33.456271,"eighty":-26.43668,"marketCap":29618322630},{"date":"2021-12-24","current":-24.338156,"twenty":-56.834726,"median":-33.106388,"eighty":-25.505551,"marketCap":27698238266},{"date":"2021-12-31","current":-24.356969,"twenty":-56.799582,"median":-33.044261,"eighty":-25.17902,"marketCap":27779943984},{"date":"2022-01-07","current":-20.242995,"twenty":-23.086945,"median":-21.779811,"eighty":-19.899701,"marketCap":23000159504},{"date":"2022-01-14","current":-20.701287,"twenty":-22.600464,"median":-21.033383,"eighty":-20.391327,"marketCap":23572099527},{"date":"2022-01-21","current":-18.577865,"twenty":-21.986595,"median":-20.680988,"eighty":-19.350843,"marketCap":21202633717},{"date":"2022-01-28","current":-14.534275,"twenty":-21.562934,"median":-20.260299,"eighty":-18.52558,"marketCap":16545407814},{"date":"2022-02-04","current":-14.146452,"twenty":-21.41835,"median":-20.123216,"eighty":-17.613539,"marketCap":16096026367},{"date":"2022-02-11","current":-13.816944,"twenty":-21.209422,"median":-19.299968,"eighty":-14.985471,"marketCap":15752862353},{"date":"2022-02-18","current":-13.849256,"twenty":-20.857344,"median":-18.911796,"eighty":-14.543623,"marketCap":15867250357},{"date":"2022-02-25","current":-14.199347,"twenty":-20.701287,"median":-17.613539,"eighty":-14.146452,"marketCap":16308461232},{"date":"2022-03-04","current":-14.080132,"twenty":-20.680988,"median":-15.318994,"eighty":-14.146452,"marketCap":16177732084},{"date":"2022-03-11","current":-11.936356,"twenty":-20.490215,"median":-14.985471,"eighty":-13.996814,"marketCap":13693878269},{"date":"2022-03-18","current":-11.726724,"twenty":-20.277602,"median":-14.700549,"eighty":-13.379502,"marketCap":13399737686},{"date":"2022-03-25","current":-12.670051,"twenty":-20.242995,"median":-14.554967,"eighty":-13.072377,"marketCap":14478253158},{"date":"2022-04-01","current":-9.59311,"twenty":-20.003436,"median":-14.538949,"eighty":-12.331764,"marketCap":12697068515},{"date":"2022-04-08","current":-10.156641,"twenty":-19.508494,"median":-14.196743,"eighty":-11.833638,"marketCap":13448761116},{"date":"2022-04-14","current":-9.530673,"twenty":-19.333884,"median":-14.131899,"eighty":-11.51878,"marketCap":12599021653},{"date":"2022-04-22","current":-8.780037,"twenty":-19.299831,"median":-14.060726,"eighty":-10.573986,"marketCap":11389777033},{"date":"2022-04-29","current":-9.576611,"twenty":-19.278065,"median":-13.849256,"eighty":-10.115287,"marketCap":12223175352},{"date":"2022-05-06","current":-7.86231,"twenty":-19.112154,"median":-13.498553,"eighty":-9.579911,"marketCap":9951756403},{"date":"2022-05-13","current":-8.110711,"twenty":-18.577865,"median":-13.379502,"eighty":-9.437455,"marketCap":10082485551},{"date":"2022-05-20","current":-9.061494,"twenty":-18.447152,"median":-13.096379,"eighty":-8.947629,"marketCap":11422459320},{"date":"2022-05-27","current":-8.809867,"twenty":-17.613539,"median":-12.670051,"eighty":-8.780037,"marketCap":11095636450},{"date":"2022-06-02","current":-11.227787,"twenty":-16.802517,"median":-12.331764,"eighty":-8.803901,"marketCap":14216794862},{"date":"2022-06-10","current":-12.109337,"twenty":-15.675042,"median":-12.221978,"eighty":-8.825148,"marketCap":15229945760},{"date":"2022-06-17","current":-11.667379,"twenty":-15.244074,"median":-11.936356,"eighty":-8.923897,"marketCap":14658005737},{"date":"2022-06-24","current":-16.485913,"twenty":-15.494316,"median":-12.221978,"eighty":-9.038721,"marketCap":20794105129},{"date":"2022-06-30","current":-14.957001,"twenty":-15.895364,"median":-12.380422,"eighty":-9.079607,"marketCap":18833167906},{"date":"2022-07-08","current":-15.913959,"twenty":-16.531452,"median":-12.638751,"eighty":-9.104893,"marketCap":20058753670},{"date":"2022-07-15","current":-15.322331,"twenty":-16.45611,"median":-12.887919,"eighty":-9.149933,"marketCap":19134050754},{"date":"2022-07-22","current":-14.807486,"twenty":-16.221667,"median":-13.200862,"eighty":-9.216155,"marketCap":18503257872},{"date":"2022-07-29","current":-14.117198,"twenty":-15.979822,"median":-13.449665,"eighty":-9.360153,"marketCap":17662200696},{"date":"2022-08-05","current":-15.298986,"twenty":-15.838747,"median":-13.498553,"eighty":-9.442,"marketCap":19091997895},{"date":"2022-08-12","current":-15.143556,"twenty":-15.77936,"median":-13.923035,"eighty":-9.496416,"marketCap":18923786460},{"date":"2022-08-19","current":-14.616817,"twenty":-15.77936,"median":-14.080132,"eighty":-9.558236,"marketCap":18082729284},{"date":"2022-08-26","current":-14.756101,"twenty":-15.738632,"median":-14.060726,"eighty":-9.58651,"marketCap":21573116564},{"date":"2022-09-02","current":-14.751536,"twenty":-15.714766,"median":-14.080132,"eighty":-9.724865,"marketCap":21489010846},{"date":"2022-09-09","current":-14.98178,"twenty":-15.703366,"median":-14.105484,"eighty":-9.977712,"marketCap":21741327999},{"date":"2022-09-16","current":-13.542084,"twenty":-15.658514,"median":-14.086951,"eighty":-10.115287,"marketCap":19470473624},{"date":"2022-09-23","current":-12.107338,"twenty":-15.550768,"median":-14.041319,"eighty":-10.199224,"marketCap":17073460672},{"date":"2022-09-30","current":-12.91765,"twenty":-15.461818,"median":-13.978573,"eighty":-10.287783,"marketCap":18250940719},{"date":"2022-10-07","current":-16.281937,"twenty":-15.588998,"median":-14.018764,"eighty":-10.343921,"marketCap":23002913763},{"date":"2022-10-14","current":-15.674276,"twenty":-15.588998,"median":-14.040715,"eighty":-10.440625,"marketCap":21909539434},{"date":"2022-10-21","current":-18.781307,"twenty":-15.710601,"median":-14.070137,"eighty":-10.570074,"marketCap":26072772456},{"date":"2022-10-28","current":-18.085263,"twenty":-15.888888,"median":-14.117198,"eighty":-10.76408,"marketCap":25063503844},{"date":"2022-11-04","current":-18.001131,"twenty":-16.380537,"median":-14.170295,"eighty":-10.773453,"marketCap":25189662421},{"date":"2022-11-11","current":-17.246398,"twenty":-16.644748,"median":-14.199347,"eighty":-10.843556,"marketCap":24348605245},{"date":"2022-11-18","current":-21.310798,"twenty":-17.050284,"median":-14.308051,"eighty":-11.043704,"marketCap":29983688324},{"date":"2022-11-25","current":-18.980602,"twenty":-17.498612,"median":-14.382807,"eighty":-11.22006,"marketCap":26493301044},{"date":"2022-12-02","current":-19.013979,"twenty":-17.995008,"median":-14.534799,"eighty":-11.242055,"marketCap":26997935349},{"date":"2022-12-09","current":-24.062263,"twenty":-18.437795,"median":-14.543856,"eighty":-11.359054,"marketCap":34483344216},{"date":"2022-12-16","current":-24.530301,"twenty":-18.889555,"median":-14.574904,"eighty":-11.602588,"marketCap":35072084239},{"date":"2022-12-23","current":-25.228352,"twenty":-19.041941,"median":-14.612379,"eighty":-11.627361,"marketCap":36081352850},{"date":"2022-12-30","current":-24.983629,"twenty":-19.09779,"median":-14.616563,"eighty":-11.655751,"marketCap":36165458568},{"date":"2023-01-06","current":-26.109825,"twenty":-19.246994,"median":-14.727609,"eighty":-11.666513,"marketCap":38183995790},{"date":"2023-01-13","current":-27.482086,"twenty":-19.35432,"median":-14.788719,"eighty":-11.675194,"marketCap":40959484471},{"date":"2023-01-20","current":-27.207673,"twenty":-19.72973,"median":-14.927803,"eighty":-11.681264,"marketCap":40202533012},{"date":"2023-01-27","current":-29.02317,"twenty":-19.973183,"median":-14.953302,"eighty":-11.681837,"marketCap":42893915976},{"date":"2023-02-03","current":-27.684735,"twenty":-20.135985,"median":-14.979187,"eighty":-11.694899,"marketCap":41127695906},{"date":"2023-02-10","current":-25.345976,"twenty":-20.490215,"median":-14.987339,"eighty":-11.726724,"marketCap":37427044332},{"date":"2023-02-17","current":-24.322978,"twenty":-20.857344,"median":-15.034554,"eighty":-11.784491,"marketCap":35576718544},{"date":"2023-02-24","current":-24.100109,"twenty":-21.41835,"median":-15.060613,"eighty":-11.860367,"marketCap":34819767086},{"date":"2023-03-03","current":-25.36278,"twenty":-22.807081,"median":-15.131721,"eighty":-11.936356,"marketCap":36880357167},{"date":"2023-03-10","current":-22.900092,"twenty":-23.768741,"median":-23.203261,"eighty":-23.03994,"marketCap":33053547016},{"date":"2023-03-17","current":-29.09369,"twenty":-36.802165,"median":-25.36278,"eighty":-15.020812,"marketCap":38688630096},{"date":"2023-03-24","current":-25.324343,"twenty":-36.777216,"median":-25.389232,"eighty":-15.036479,"marketCap":34062815628},{"date":"2023-03-31","current":-25.456261,"twenty":-36.704597,"median":-25.488573,"eighty":-15.049117,"marketCap":33978709910},{"date":"2023-04-06","current":-27.774061,"twenty":-36.623868,"median":-25.540624,"eighty":-15.058257,"marketCap":37048568602},{"date":"2023-04-14","current":-29.730818,"twenty":-36.485136,"median":-25.637411,"eighty":-15.064541,"marketCap":39697898707},{"date":"2023-04-21","current":-26.784111,"twenty":-36.470425,"median":-25.724076,"eighty":-15.129637,"marketCap":35744929980},{"date":"2023-04-28","current":-27.207269,"twenty":-36.436465,"median":-26.010547,"eighty":-15.131721,"marketCap":36039299991},{"date":"2023-05-05","current":-28.335447,"twenty":-36.311562,"median":-26.064869,"eighty":-15.141189,"marketCap":37595255767},{"date":"2023-05-12","current":-27.159579,"twenty":-36.18971,"median":-26.086367,"eighty":-15.143863,"marketCap":35786982838},{"date":"2023-05-19","current":-24.342298,"twenty":-36.161524,"median":-26.085247,"eighty":-15.156,"marketCap":31623749817},{"date":"2023-05-25","current":-24.063272,"twenty":-36.158475,"median":-26.064869,"eighty":-15.180082,"marketCap":31203221229},{"date":"2023-06-02","current":-23.645458,"twenty":-36.149195,"median":-25.984476,"eighty":-15.257042,"marketCap":30488322630},{"date":"2023-06-09","current":-23.222359,"twenty":-36.112659,"median":-25.723039,"eighty":-15.312993,"marketCap":29899582606},{"date":"2023-06-16","current":-24.58122,"twenty":-36.07905,"median":-25.633881,"eighty":-15.343575,"marketCap":31497591241},{"date":"2023-06-23","current":-21.944137,"twenty":-36.043198,"median":-25.488573,"eighty":-15.365065,"marketCap":27965151102},{"date":"2023-06-30","current":-23.543047,"twenty":-35.998611,"median":-25.389232,"eighty":-15.403178,"marketCap":29731371171},{"date":"2023-07-07","current":-23.989446,"twenty":-35.969849,"median":-25.36278,"eighty":-15.455833,"marketCap":30236005477},{"date":"2023-07-14","current":-24.41425,"twenty":-35.912278,"median":-25.312393,"eighty":-15.498928,"marketCap":31203221229},{"date":"2023-07-21","current":-24.59436,"twenty":-35.843663,"median":-25.202538,"eighty":-15.562817,"marketCap":31287326947},{"date":"2023-07-28","current":-28.426335,"twenty":-35.766034,"median":-25.264398,"eighty":-15.623426,"marketCap":36123405709},{"date":"2023-08-04","current":-24.11733,"twenty":-35.704573,"median":-25.300444,"eighty":-15.66297,"marketCap":30698586924},{"date":"2023-08-11","current":-22.294,"twenty":-35.666275,"median":-25.201022,"eighty":-15.683018,"marketCap":28217468254},{"date":"2023-08-18","current":-21.752014,"twenty":-35.64615,"median":-25.173816,"eighty":-15.703366,"marketCap":27334358220},{"date":"2023-08-25","current":-22.10921,"twenty":-35.616771,"median":-25.07893,"eighty":-15.714766,"marketCap":27796939666},{"date":"2023-09-01","current":13.494719,"twenty":-35.601124,"median":-25.008455,"eighty":-15.66297,"marketCap":28974419713},{"date":"2023-09-08","current":13.695117,"twenty":-35.550756,"median":-24.944029,"eighty":-15.455833,"marketCap":29058525430},{"date":"2023-09-15","current":14.848421,"twenty":-35.47221,"median":-24.903626,"eighty":-15.308324,"marketCap":31749908394},{"date":"2023-09-22","current":14.814862,"twenty":-35.438003,"median":-24.827647,"eighty":-15.14371,"marketCap":31539644100},{"date":"2023-09-29","current":14.197918,"twenty":-35.396385,"median":-24.772153,"eighty":-15.059828,"marketCap":30278058336},{"date":"2023-10-06","current":13.889059,"twenty":-35.370319,"median":-24.700469,"eighty":-15.007069,"marketCap":29605212595},{"date":"2023-10-13","current":15.431226,"twenty":-35.30592,"median":-24.632761,"eighty":-14.979706,"marketCap":32843282722},{"date":"2023-10-20","current":14.94053,"twenty":-35.232247,"median":-24.59436,"eighty":-14.914724,"marketCap":31749908394},{"date":"2023-10-27","current":16.35255,"twenty":-35.175876,"median":-24.58122,"eighty":-14.756101,"marketCap":34735661368},{"date":"2023-11-03","current":17.592659,"twenty":-35.129074,"median":-24.511377,"eighty":-14.616308,"marketCap":37469097190},{"date":"2023-11-10","current":18.939266,"twenty":-34.971061,"median":-24.417444,"eighty":-14.569406,"marketCap":40328691589},{"date":"2023-11-17","current":18.319814,"twenty":-34.968612,"median":-24.399566,"eighty":-14.535322,"marketCap":39361475836},{"date":"2023-11-24","current":18.189638,"twenty":-34.895357,"median":-24.342298,"eighty":-14.371526,"marketCap":39403528695},{"date":"2023-12-01","current":18.752497,"twenty":-34.737009,"median":-24.330293,"eighty":-14.199347,"marketCap":40791273036},{"date":"2023-12-08","current":16.771041,"twenty":-34.685609,"median":-24.255162,"eighty":-14.117346,"marketCap":36333670003},{"date":"2023-12-15","current":17.832719,"twenty":-34.615488,"median":-24.15298,"eighty":-14.060142,"marketCap":38856841531},{"date":"2023-12-22","current":16.203086,"twenty":-34.602221,"median":-24.100109,"eighty":-13.960331,"marketCap":35282348533},{"date":"2023-12-29","current":17.826838,"twenty":-34.566441,"median":-24.075355,"eighty":-13.84838,"marketCap":39025052966},{"date":"2024-01-05","current":16.831364,"twenty":-34.502078,"median":-24.025855,"eighty":-13.7643,"marketCap":36585987156},{"date":"2024-01-12","current":17.634525,"twenty":-34.43816,"median":-23.91516,"eighty":-13.515965,"marketCap":38352207225},{"date":"2024-01-19","current":16.051677,"twenty":-34.428025,"median":-23.817977,"eighty":-13.388012,"marketCap":34861819945},{"date":"2024-01-26","current":16.269899,"twenty":-34.417805,"median":-23.667454,"eighty":-13.261099,"marketCap":35198242815},{"date":"2024-02-02","current":15.531605,"twenty":-34.408725,"median":-23.587311,"eighty":-13.092715,"marketCap":33558181322},{"date":"2024-02-09","current":15.823479,"twenty":-34.287198,"median":-23.509747,"eighty":-12.88456,"marketCap":34357185639},{"date":"2024-02-16","current":17.001239,"twenty":-34.118192,"median":-23.29296,"eighty":-12.670051,"marketCap":36922410026},{"date":"2024-02-23","current":17.733723,"twenty":-34.052175,"median":-23.261464,"eighty":-12.429079,"marketCap":38310154366},{"date":"2024-03-01","current":18.170113,"twenty":-33.918444,"median":-23.222586,"eighty":-12.109337,"marketCap":39277370119},{"date":"2024-03-08","current":18.375936,"twenty":-33.875196,"median":-23.212231,"eighty":-11.784491,"marketCap":39739951566},{"date":"2024-03-15","current":20.221708,"twenty":-33.786096,"median":-23.186995,"eighty":-11.680404,"marketCap":43692920293},{"date":"2024-03-22","current":17.596046,"twenty":-33.777607,"median":-23.165857,"eighty":-11.598761,"marketCap":38772735813},{"date":"2024-03-28","current":17.863111,"twenty":-33.671621,"median":-23.133172,"eighty":-11.174522,"marketCap":39235317260},{"date":"2024-04-05","current":17.790526,"twenty":-33.631134,"median":-23.073507,"eighty":-10.781195,"marketCap":39050158637},{"date":"2024-04-12","current":19.515107,"twenty":-33.600204,"median":-23.002422,"eighty":-10.363031,"marketCap":42859930212},{"date":"2024-04-19","current":17.322126,"twenty":-33.582079,"median":-22.887987,"eighty":-9.922708,"marketCap":38011130026},{"date":"2024-04-26","current":19.239838,"twenty":-33.576561,"median":-22.815578,"eighty":-9.479287,"marketCap":42167244471},{"date":"2024-05-03","current":19.371749,"twenty":-33.573712,"median":-22.807081,"eighty":-9.18811,"marketCap":42427001624},{"date":"2024-05-10","current":19.700553,"twenty":-33.522448,"median":-22.755385,"eighty":-8.970402,"marketCap":43249565941},{"date":"2024-05-17","current":19.23578,"twenty":-33.345978,"median":-22.735553,"eighty":-8.780037,"marketCap":42167244471},{"date":"2024-05-24","current":14.667701,"twenty":-33.217784,"median":-22.607363,"eighty":-8.675073,"marketCap":32080008370},{"date":"2024-05-31","current":17.401421,"twenty":-33.106388,"median":-22.460124,"eighty":-8.554056,"marketCap":38097715744},{"date":"2024-06-07","current":16.096502,"twenty":-33.061925,"median":-22.417733,"eighty":-8.291628,"marketCap":35197094204},{"date":"2024-06-14","current":15.794192,"twenty":-33.047794,"median":-22.339227,"eighty":-8.117822,"marketCap":34504408463},{"date":"2024-06-21","current":14.159201,"twenty":-33.01008,"median":-22.315076,"eighty":-7.860137,"marketCap":30867808324},{"date":"2024-06-28","current":14.999486,"twenty":-32.90826,"median":-22.280642,"eighty":13.494356,"marketCap":32686108394},{"date":"2024-07-05","current":15.459781,"twenty":-32.881624,"median":-22.258985,"eighty":13.627238,"marketCap":33681844146},{"date":"2024-07-12","current":15.952998,"twenty":-32.86657,"median":-22.065202,"eighty":13.703744,"marketCap":34807458475},{"date":"2024-07-19","current":15.972541,"twenty":-32.832239,"median":-21.944137,"eighty":13.863497,"marketCap":34850751334},{"date":"2024-07-26","current":16.071567,"twenty":-32.814226,"median":-21.7966,"eighty":14.148348,"marketCap":35197094204},{"date":"2024-08-02","current":16.61499,"twenty":-32.811697,"median":-21.752014,"eighty":14.411832,"marketCap":36366001392},{"date":"2024-08-09","current":17.212345,"twenty":-32.808943,"median":-21.597174,"eighty":14.509977,"marketCap":37924544308},{"date":"2024-08-16","current":17.657405,"twenty":-32.804956,"median":-21.439655,"eighty":14.640353,"marketCap":38920280061},{"date":"2024-08-23","current":17.9547,"twenty":-32.79969,"median":-21.418042,"eighty":14.703604,"marketCap":39742844378},{"date":"2024-08-30","current":-52.624506,"twenty":-32.804956,"median":-21.417734,"eighty":14.818346,"marketCap":42513587341},{"date":"2024-09-06","current":-51.635037,"twenty":-32.832239,"median":-21.438942,"eighty":14.78042,"marketCap":41734315883},{"date":"2024-09-13","current":-66.216902,"twenty":-33.018625,"median":-21.520592,"eighty":14.703604,"marketCap":53380094900},{"date":"2024-09-20","current":-69.932725,"twenty":-33.173226,"median":-21.714319,"eighty":14.662246,"marketCap":56713645028},{"date":"2024-09-27","current":-71.531113,"twenty":-33.576561,"median":-21.771586,"eighty":14.652247,"marketCap":58358773662},{"date":"2024-10-04","current":-79.320454,"twenty":-33.638129,"median":-21.813706,"eighty":14.649255,"marketCap":64419773894},{"date":"2024-10-10","current":-69.213885,"twenty":-33.875196,"median":-21.986037,"eighty":14.648182,"marketCap":55847787852},{"date":"2024-10-18","current":-74.646599,"twenty":-34.399868,"median":-22.081407,"eighty":14.635134,"marketCap":59917316579},{"date":"2024-10-25","current":-77.719883,"twenty":-34.441314,"median":-22.265924,"eighty":14.560741,"marketCap":62380223732},{"date":"2024-11-01","current":-76.214752,"twenty":-34.685609,"median":-22.294,"eighty":14.556702,"marketCap":61213399403},{"date":"2024-11-08","current":-76.2814,"twenty":-34.971061,"median":-22.333531,"eighty":14.515997,"marketCap":60989010109},{"date":"2024-11-15","current":-78.00551,"twenty":-35.320815,"median":-22.40582,"eighty":14.505964,"marketCap":61707055850},{"date":"2024-11-22","current":-81.958791,"twenty":-35.480573,"median":-22.437728,"eighty":14.479729,"marketCap":64803628107},{"date":"2024-11-29","current":-83.036127,"twenty":-35.659842,"median":-22.470599,"eighty":14.463817,"marketCap":65611429565},{"date":"2024-12-06","current":-74.237179,"twenty":-35.878177,"median":-22.720101,"eighty":14.435399,"marketCap":58520727875},{"date":"2024-12-13","current":-72.615659,"twenty":-36.070462,"median":-22.745547,"eighty":14.396121,"marketCap":57129514252},{"date":"2024-12-20","current":-69.730236,"twenty":-36.160141,"median":-22.79318,"eighty":14.28027,"marketCap":54616354159},{"date":"2024-12-27","current":-68.121477,"twenty":-36.342788,"median":-22.81524,"eighty":14.230859,"marketCap":53314896254},{"date":"2025-01-03","current":-66.794572,"twenty":-36.589185,"median":-22.863096,"eighty":14.182431,"marketCap":52327583360},{"date":"2025-01-10","current":-64.575988,"twenty":-36.921451,"median":-22.916115,"eighty":14.151966,"marketCap":50397835432},{"date":"2025-01-17","current":-67.97132,"twenty":-37.388459,"median":-23.037405,"eighty":14.124517,"marketCap":53090506960},{"date":"2025-01-24","current":-71.487894,"twenty":-37.630978,"median":-23.112092,"eighty":14.06824,"marketCap":56187079217},{"date":"2025-01-28","current":-69.159217,"twenty":-37.749998,"median":-23.133265,"eighty":14.036856,"marketCap":54616354159},{"date":"2025-02-07","current":-74.204707,"twenty":-38.720974,"median":-23.179575,"eighty":13.91548,"marketCap":58296338581},{"date":"2025-02-14","current":-68.942526,"twenty":-39.742666,"median":-23.199597,"eighty":13.854976,"marketCap":54032941995},{"date":"2025-02-21","current":-78.532535,"twenty":-40.936164,"median":-23.213534,"eighty":13.833941,"marketCap":61886567285},{"date":"2025-02-28","current":-83.363188,"twenty":-41.78603,"median":-23.229233,"eighty":13.752998,"marketCap":65476795989},{"date":"2025-03-07","current":-82.972913,"twenty":-43.765472,"median":-23.273351,"eighty":13.720056,"marketCap":65431918130},{"date":"2025-03-14","current":-81.918752,"twenty":-44.36559,"median":-23.404228,"eighty":13.69943,"marketCap":64624116672},{"date":"2025-03-21","current":-77.113549,"twenty":-46.703645,"median":-23.571971,"eighty":13.681934,"marketCap":60809498674},{"date":"2025-03-28","current":-85.082441,"twenty":-50.561624,"median":-23.656456,"eighty":13.67268,"marketCap":66957765329},{"date":"2025-04-03","current":-139.968555,"twenty":-51.651807,"median":-23.75284,"eighty":13.662257,"marketCap":77100161418},{"date":"2025-04-11","current":-135.149196,"twenty":-52.531592,"median":-23.854164,"eighty":13.627238,"marketCap":73779199867},{"date":"2025-04-17","current":-136.201828,"twenty":-53.202931,"median":-23.974596,"eighty":13.597708,"marketCap":74452367749},{"date":"2025-04-25","current":-162.080631,"twenty":-54.264543,"median":-23.982021,"eighty":13.592632,"marketCap":88770184906},{"date":"2025-05-02","current":-143.58439,"twenty":-55.295104,"median":-23.989446,"eighty":13.587555,"marketCap":78807100452},{"date":"2025-05-09","current":-136.980788,"twenty":-56.345373,"median":-23.982021,"eighty":13.592632,"marketCap":75710466095},{"date":"2025-05-16","current":-134.501562,"twenty":-57.376977,"median":-23.982021,"eighty":13.592632,"marketCap":74947527196},{"date":"2025-05-23","current":-133.538341,"twenty":-57.747713,"median":-23.982021,"eighty":13.592632,"marketCap":74633375884},{"date":"2025-05-30","current":-133.993142,"twenty":-58.91872,"median":-23.982021,"eighty":13.592632,"marketCap":75216799748},{"date":"2025-06-06","current":-131.180073,"twenty":-59.359698,"median":-23.982021,"eighty":13.592632,"marketCap":73825558226},{"date":"2025-06-13","current":-152.810216,"twenty":-59.540166,"median":-23.982021,"eighty":13.592632,"marketCap":86032580619},{"date":"2025-06-20","current":-145.842175,"twenty":-59.540166,"median":-23.982021,"eighty":13.592632,"marketCap":81948613568},{"date":"2025-06-27","current":-147.346424,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":83025703780},{"date":"2025-07-04","current":-184.930979,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":104208477933},{"date":"2025-07-11","current":-180.493504,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":101605509923},{"date":"2025-07-18","current":-224.51725,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":126288827263},{"date":"2025-07-25","current":-237.059172,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":133828458741},{"date":"2025-08-01","current":-250.051759,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":140291000008},{"date":"2025-08-08","current":-255.97072,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":143971058230},{"date":"2025-08-15","current":-264.505775,"twenty":-59.98102,"median":-23.989446,"eighty":13.587555,"marketCap":148548691628},{"date":"2025-08-22","current":-283.614883,"twenty":-59.98102,"median":-23.989446,"eighty":13.587555,"marketCap":158781048634},{"date":"2025-08-29","current":-151.096607,"twenty":-60.061292,"median":-23.989446,"eighty":13.587555,"marketCap":139755257503},{"date":"2025-09-05","current":-154.217836,"twenty":-62.354796,"median":-23.989446,"eighty":13.587555,"marketCap":142500849327},{"date":"2025-09-12","current":-134.834957,"twenty":-64.590671,"median":-23.989446,"eighty":13.587555,"marketCap":124814900348},{"date":"2025-09-19","current":-129.155078,"twenty":-65.225568,"median":-24.062263,"eighty":13.587555,"marketCap":119472269927},{"date":"2025-09-26","current":-132.486221,"twenty":-66.989962,"median":-24.124656,"eighty":13.587555,"marketCap":122235699455},{"date":"2025-10-03","current":-139.242464,"twenty":-67.293654,"median":-24.261227,"eighty":13.582478,"marketCap":128775816004},{"date":"2025-10-10","current":-127.67557,"twenty":-67.910041,"median":-24.342298,"eighty":13.587555,"marketCap":117906326528},{"date":"2025-10-17","current":-122.384529,"twenty":-68.235995,"median":-24.417444,"eighty":13.587555,"marketCap":112932153377},{"date":"2025-10-24","current":-114.955731,"twenty":-68.842466,"median":-24.58122,"eighty":13.587555,"marketCap":106115693875},{"date":"2025-10-31","current":-112.991017,"twenty":-69.234459,"median":-24.630996,"eighty":13.587555,"marketCap":104457636158},{"date":"2025-11-07","current":-111.865223,"twenty":-69.783847,"median":-24.772153,"eighty":13.587555,"marketCap":103352264347},{"date":"2025-11-14","current":-118.110846,"twenty":-71.021734,"median":-24.903626,"eighty":13.587555,"marketCap":109431809308},{"date":"2025-11-21","current":-106.428879,"twenty":-71.496538,"median":-25.008455,"eighty":13.587555,"marketCap":98562319832},{"date":"2025-11-28","current":-121.801586,"twenty":-72.238759,"median":-25.173816,"eighty":13.587555,"marketCap":113208496330},{"date":"2025-12-05","current":-122.779771,"twenty":-72.794834,"median":-25.300444,"eighty":13.587555,"marketCap":114313868141},{"date":"2025-12-12","current":-122.948103,"twenty":-73.382927,"median":-25.403597,"eighty":13.587555,"marketCap":114682325412},{"date":"2025-12-19","current":-115.46697,"twenty":-74.211201,"median":-25.633881,"eighty":13.587555,"marketCap":107957980227},{"date":"2025-12-24","current":-110.590517,"twenty":-74.659967,"median":-25.640942,"eighty":13.587555,"marketCap":103720721617},{"date":"2026-01-02","current":-110.841788,"twenty":-75.482016,"median":-25.637411,"eighty":13.592632,"marketCap":104365521840},{"date":"2026-01-09","current":-124.521475,"twenty":-75.983701,"median":-25.679301,"eighty":13.547374,"marketCap":117537869257},{"date":"2026-01-16","current":-117.698232,"twenty":-76.738768,"median":-25.679301,"eighty":13.547374,"marketCap":111458324296},{"date":"2026-01-23","current":-113.429847,"twenty":-77.350039,"median":-25.679301,"eighty":13.547374,"marketCap":107313180004},{"date":"2026-01-30","current":-107.001444,"twenty":-78.004549,"median":-25.679301,"eighty":13.547374,"marketCap":101694206630},{"date":"2026-02-06","current":-97.546473,"twenty":-79.287468,"median":-25.773598,"eighty":13.494628,"marketCap":92943346458},{"date":"2026-02-13","current":-101.218847,"twenty":-80.266586,"median":-25.825195,"eighty":13.494537,"marketCap":96996376432},{"date":"2026-02-20","current":-105.022841,"twenty":-80.777808,"median":-25.722001,"eighty":13.494719,"marketCap":100496720501},{"date":"2026-02-27","current":-101.788736,"twenty":-81.405078,"median":-25.722001,"eighty":13.494719,"marketCap":98470205514},{"date":"2026-03-06","current":-102.999959,"twenty":-82.133452,"median":-25.722001,"eighty":13.494719,"marketCap":98838662784},{"date":"2026-03-13","current":-105.298763,"twenty":-83.363188,"median":-25.722001,"eighty":13.494719,"marketCap":101509977995},{"date":"2026-03-20","current":-110.878439,"twenty":-84.977693,"median":-25.773598,"eighty":13.494628,"marketCap":106484151145},{"date":"2026-03-27","current":-92.387071,"twenty":-90.917747,"median":-25.773598,"eighty":13.494628,"marketCap":116432497446},{"date":"2026-04-02","current":-102.201748,"twenty":-96.788708,"median":-25.773598,"eighty":13.494628,"marketCap":129420616228},{"date":"2026-04-10","current":-99.759281,"twenty":-97.56233,"median":-25.773598,"eighty":13.494628,"marketCap":127301986923},{"date":"2026-04-17","current":-108.953175,"twenty":-98.069701,"median":-25.773598,"eighty":13.494628,"marketCap":139092619576},{"date":"2026-04-24","current":-94.949835,"twenty":-99.339337,"median":-25.773598,"eighty":13.494628,"marketCap":121222441961},{"date":"2026-04-30","current":-97.955024,"twenty":-99.339337,"median":-25.773598,"eighty":13.494628,"marketCap":125091243300},{"date":"2026-05-08","current":-96.322328,"twenty":-99.339337,"median":-25.773598,"eighty":13.494628,"marketCap":123433185584},{"date":"2026-05-15","current":-86.175907,"twenty":-99.339337,"median":-25.773598,"eighty":13.494628,"marketCap":110721409755},{"date":"2026-05-22","current":-83.786417,"twenty":-99.331319,"median":-25.825195,"eighty":13.494537,"marketCap":107405294321},{"date":"2026-05-29","current":-84.570211,"twenty":-99.339337,"median":-25.773598,"eighty":13.494628,"marketCap":108787009085},{"date":"2026-06-05","current":-66.928875,"twenty":-99.331319,"median":-25.825195,"eighty":13.494537,"marketCap":86219001273},{"date":"2026-06-12","current":-65.829318,"twenty":-99.323302,"median":-25.904836,"eighty":13.494447,"marketCap":84745172192},{"date":"2026-06-18","current":-62.495243,"twenty":-99.315284,"median":-25.984476,"eighty":13.494356,"marketCap":80646085058},{"date":"2026-06-26","current":-59.753298,"twenty":-99.323302,"median":-25.904836,"eighty":13.494447,"marketCap":76731226560},{"date":"2026-07-03","current":-73.399324,"twenty":-99.315284,"median":-25.984476,"eighty":13.494356,"marketCap":94325061222},{"date":"2026-07-10","current":-69.793507,"twenty":-99.315284,"median":-25.984476,"eighty":13.494356,"marketCap":89581173866},{"date":"2026-07-17","current":-63.181388,"twenty":-99.315284,"median":-25.984476,"eighty":13.494356,"marketCap":81382999599},{"date":"2026-07-24","current":-71.139059,"twenty":-99.315284,"median":-25.984476,"eighty":13.494356,"marketCap":91653746012},{"date":"2026-07-31","current":-67.043638,"twenty":-99.323302,"median":-25.904836,"eighty":13.494447,"marketCap":86541401385},{"date":"2026-08-07","current":-71.222684,"twenty":-99.323302,"median":-25.904836,"eighty":13.494447,"marketCap":92114317600},{"date":"2026-08-14","current":-68.287327,"twenty":-99.323302,"median":-26.043394,"eighty":13.494447,"marketCap":88429744896},{"date":"2026-08-21","current":-64.055639,"twenty":-99.315284,"median":-26.109825,"eighty":13.494356,"marketCap":83133171634},{"date":"2026-08-28","current":-77.864086,"twenty":-99.292622,"median":-26.202149,"eighty":13.326528,"marketCap":87831001831},{"date":"2026-09-04","current":-82.608113,"twenty":-99.277979,"median":-26.442363,"eighty":13.158791,"marketCap":93219689411},{"date":"2026-09-11","current":-73.61126,"twenty":-99.277979,"median":-26.442363,"eighty":13.158791,"marketCap":83179228792},{"date":"2026-09-18","current":-73.678029,"twenty":-99.277979,"median":-26.442363,"eighty":13.158791,"marketCap":83363457428},{"date":"2026-09-25","current":-76.306531,"twenty":-99.263335,"median":-26.445589,"eighty":12.991053,"marketCap":86172944114},{"date":"2026-09-30","current":-88.498925,"twenty":-99.263335,"median":-26.445589,"eighty":12.991053,"marketCap":100128263231}],"updateTime":1790867563235},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09926\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660244894","title":"Akeso (SEHK:9926) Could Be 47% Undervalued As China Approves Ivonescimab Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2660244894","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660244894?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:20","pubTimestamp":1787149244,"startTime":"0","endTime":"0","summary":"Akeso (SEHK:9926) is back in focus after China’s National Medical Products Administration approved ivonescimab plus chemotherapy as a first-line treatment for advanced squamous non-small cell lung cancer.\nSee our latest analysis for Akeso.\nDespite the positive ivonescimab news, Akeso’s share price has come under pressure, with the stock down 12.54% over the past week and 21.18% year to date. At the same time, the 3 year total shareholder return of 185.76% and 5 year total shareholder return...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-47-undervalued-as-china-approves-ivo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-47-undervalued-as-china-approves-ivo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1794554557.SGD","LU0634319403.HKD","LU0348825331.USD","LU0348827113.USD","LU2476274720.SGD","LU2778985437.USD","LU0540923850.HKD","IE00B5MMRT66.SGD","LU0348784397.USD","LU0348766576.USD","LU0348783233.USD","IE00B543WZ88.USD","KURE","LU2399975544.HKD","LU0417516571.SGD","LU1720050803.USD","LU0348735423.USD","09926","LU2476274308.USD","LU0348767384.USD","LU0417516738.SGD","LU2488822045.USD","BK1161","BK1574","IE00BPRC5H50.USD","LU0417516902.SGD","LU0561508036.HKD","LU1961090484.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121106401","title":"Movement Alert｜AKESO Falls 3.09% in Regular Trading, Profit-Taking Continues After Third Indication Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1121106401","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121106401?lang=en_us&edition=fundamental","pubTime":"2026-08-18 09:52","pubTimestamp":1787017929,"startTime":"0","endTime":"0","summary":"On August 18, AKESO fell 3.09% in regular trading, trading at HK$87.7/share, with turnover of HK$285 million. The stock extended its multi-day decline as profit-taking pressure persisted following...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"AKESO Falls as Profit-Taking Continues After Third Indication Approval","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106186276","title":"Movement Alert｜AKESO Falls 3.49% in Regular Trading, Profit-Taking Continues After Third Indication Approval for Ivonescimab","url":"https://stock-news.laohu8.com/highlight/detail?id=1106186276","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106186276?lang=en_us&edition=fundamental","pubTime":"2026-08-17 09:33","pubTimestamp":1786930397,"startTime":"0","endTime":"0","summary":"On August 17, AKESO fell 3.49% in regular trading, trading at 91.0 HKD/share, with turnover of HKD 175 million. The decline reflects sustained profit-taking pressure following the company's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"AKESO Falls as Profit-Taking Continues After Third Indication Approval for Ivonescimab\n","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659114901","title":"What Does Akeso (SEHK:9926) China Lung Cancer Approval Mean For Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2659114901","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659114901?lang=en_us&edition=fundamental","pubTime":"2026-08-14 13:22","pubTimestamp":1786684922,"startTime":"0","endTime":"0","summary":"Akeso (SEHK:9926) received regulatory approval in China for ivonescimab plus chemotherapy as a first-line treatment for advanced squamous non small cell lung cancer.\nThe decision establishes ivonescimab combination therapy as a new standard of care for this patient group in China.\nThe approval follows Phase III data that were presented at ASCO and published in The Lancet, which underscores international clinical recognition.\n\nFor investors tracking how new oncology drugs and clinical data...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/what-does-akeso-sehk9926-china-lung-cancer-approval-mean-for","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/what-does-akeso-sehk9926-china-lung-cancer-approval-mean-for","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2778985437.USD","LU2488822045.USD","LU2476274308.USD","09926","LU0417516902.SGD","LU0348825331.USD","LU0348766576.USD","LU2399975544.HKD","LU0417516738.SGD","LU0561508036.HKD","LU0348827113.USD","LU0634319403.HKD","LU0348735423.USD","BK4211","LU1961090484.USD","BK1161","KURE","LU0540923850.HKD","IE00B543WZ88.USD","LU0348783233.USD","LU0417516571.SGD","ISBC","LU1794554557.SGD","LU0348767384.USD","LU0348784397.USD","IE00BPRC5H50.USD","LU1720050803.USD","LU2476274720.SGD","BK1574","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120959165","title":"Movement Alert｜AKESO Falls 3.19% in Regular Trading, Biotech Sector Broadly Under Pressure After Third Indication Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1120959165","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120959165?lang=en_us&edition=fundamental","pubTime":"2026-08-14 09:36","pubTimestamp":1786671394,"startTime":"0","endTime":"0","summary":"On August 14, AKESO fell 3.19% in regular trading, trading at 100.4 HKD/share, with turnover of HKD 112 million.Despite the company announcing on August 12 that its core product Ivonescimab...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659049182","title":"Akeso's Ivonescimab Gets Third Indication Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2659049182","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659049182?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:36","pubTimestamp":1786588580,"startTime":"0","endTime":"0","summary":"Akeso  said ivonescimab has been approved in China for a third indication, according to a Wednesday filing with the Hong Kong Exchange.The approval covers the use of ivonescimab in combination with chemotherapy as a first-line treatment for patients with squamous non-small cell lung cancer .This marks the third major authorization for an ivonescimab-containing regimen in China since the molecule's initial approval in May 2024.The drug was previously approved in May 2024 for EGFR-mutated locally advanced or metastatic non-squamous NSCLC patients who progressed after EGFR TKI treatment, and in April 2025 as a first-line treatment for locally advanced or metastatic NSCLC with PD-L1-positive expression.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0634319403.HKD","LU1720050803.USD","09926","LU0561508036.HKD","LU2476274308.USD","IE00B543WZ88.USD","LU0540923850.HKD","BK1161","LU2488822045.USD","LU2399975544.HKD","IE00B5MMRT66.SGD","LU0348766576.USD","LU2476274720.SGD","LU0348735423.USD","LU0348827113.USD","LU0348783233.USD","LU0348767384.USD","LU0417516571.SGD","IE00BPRC5H50.USD","LU2778985437.USD","LU0417516902.SGD","KURE","LU1961090484.USD","LU0417516738.SGD","BK1574","LU0348825331.USD","LU1794554557.SGD","LU0348784397.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183521922","title":"Movement Alert｜AKESO Rises 3.04% in Regular Trading, Third Indication of Bispecific Antibody Ivonescimab Approved by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1183521922","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183521922?lang=en_us&edition=fundamental","pubTime":"2026-08-13 09:39","pubTimestamp":1786585192,"startTime":"0","endTime":"0","summary":"On August 13, AKESO rose 3.04% in regular trading, trading at 104.7 HKD/share, with turnover of approximately HKD 103 million.On the news front, AKESO announced on August 12 that its self-developed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659904569","title":"Akeso Says NMPA Approves Ivonescimab for 1L Treatment of SQ-NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2659904569","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659904569?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:47","pubTimestamp":1786556839,"startTime":"0","endTime":"0","summary":"BRIEF-Akeso Says NMPA Approves Ivonescimab For 1L Treatment Of SQ-NSCLCAug 12 (Reuters)-Akeso Inc9926.HK:NMPA APPROVES IVONESCIMAB FOR 1L TREATMENT OF SQ-NSCLCFurther company coverage:9926.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4491E1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348766576.USD","LU1961090484.USD","LU2476274720.SGD","LU0417516738.SGD","LU0348827113.USD","LU0417516571.SGD","09926","IE00BPRC5H50.USD","LU0348784397.USD","LU0417516902.SGD","LU1720050803.USD","LU0348767384.USD","LU2399975544.HKD","LU0348783233.USD","BK1574","LU0634319403.HKD","IE00B543WZ88.USD","LU2778985437.USD","LU1794554557.SGD","BK1161","LU0561508036.HKD","LU2488822045.USD","LU0540923850.HKD","LU2476274308.USD","LU0348735423.USD","IE00B5MMRT66.SGD","KURE","LU0348825331.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908461","title":"Summit Gains After Partner Akeso Secures China Nod for Lung Cancer Combo","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908461","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908461?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:42","pubTimestamp":1786542133,"startTime":"0","endTime":"0","summary":"BUZZ-Summit gains after partner Akeso secures China nod for lung cancer combo** Shares of Summit TherapeuticsSMMT.Orise 3% to $15.58** Co says its partner Akeso9926.HKannounced the marketing authoriza","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4N44913L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348767384.USD","LU0348783233.USD","SMMT","IE00B543WZ88.USD","LU2778985437.USD","LU0540923850.HKD","LU2476274308.USD","IE00BPRC5H50.USD","LU0348735423.USD","LU1961090484.USD","KURE","LU0561508036.HKD","LU1794554557.SGD","LU0634319403.HKD","09926","LU1720050803.USD","LU2476274720.SGD","LU0348827113.USD","LU0417516571.SGD","IE00B5MMRT66.SGD","LU2488822045.USD","LU0417516902.SGD","LU0348766576.USD","LU2399975544.HKD","LU0348784397.USD","BK1161","BK4139","LU0348825331.USD","LU0417516738.SGD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147433388","title":"AKESO (09926) Gains NMPA Nod for Third Indication of Its First-in-Class Bispecific Antibody, Ivonescimab, in Frontline Squamous NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1147433388","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147433388?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:11","pubTimestamp":1786540312,"startTime":"0","endTime":"0","summary":"AKESO (09926) has announced that its independently developed, globally first-in-class bispecific antibody, Ivonescimab (marketed as Yidaifang®), has received approval from the China National Medical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0561508036.HKD","IE00B543WZ88.USD","BK1574","LU0348827113.USD","LU2488822045.USD","LU2476274308.USD","LU2778985437.USD","BK1161","KURE","LU2476274720.SGD","LU0634319403.HKD","LU0417516571.SGD","LU0417516738.SGD","LU0348735423.USD","LU0417516902.SGD","LU0348825331.USD","LU0540923850.HKD","IE00BPRC5H50.USD","LU2399975544.HKD","LU0348783233.USD","LU0348766576.USD","LU0348767384.USD","LU1169589451.USD","LU1794554557.SGD","LU1720050803.USD","LU1169590202.USD","IPOS","LU0348784397.USD","09926","PD","LU1961090484.USD","BK4023","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658970884","title":"Akeso - Nmpa Approves Ivonescimab for 1L Treatment of Sq-Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2658970884","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658970884?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:52","pubTimestamp":1786539149,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4491E1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2476274308.USD","LU2476274720.SGD","LU2488822045.USD","LU1720050803.USD","LU0561508036.HKD","LU0348825331.USD","LU0348766576.USD","BK1161","KURE","LU0348735423.USD","LU1794554557.SGD","LU0417516902.SGD","LU0348767384.USD","IE00B543WZ88.USD","LU2778985437.USD","LU0417516571.SGD","09926","IE00B5MMRT66.SGD","LU0417516738.SGD","LU1961090484.USD","LU0348783233.USD","IE00BPRC5H50.USD","BK1574","LU2399975544.HKD","LU0540923850.HKD","LU0634319403.HKD","LU0348784397.USD","LU0348827113.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972050","title":"Akeso Says China NMPA Approves Ivonescimab Plus Chemo for First-Line Squamous NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972050","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972050?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:22","pubTimestamp":1786537330,"startTime":"0","endTime":"0","summary":"Akeso says China NMPA approves ivonescimab plus chemo for first-line squamous NSCLCChina’s NMPA cleared ivonescimab with chemotherapy for first-line advanced squamous non-small cell lung cancer.Phase ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL7SlDKQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1961090484.USD","LU2476274720.SGD","LU0417516571.SGD","BK1574","LU1794554557.SGD","IE00BPRC5H50.USD","LU0348827113.USD","LU0348825331.USD","LU2399975544.HKD","LU2778985437.USD","LU2476274308.USD","LU2488822045.USD","LU0417516738.SGD","LU0348783233.USD","LU0348735423.USD","LU0540923850.HKD","LU0348766576.USD","BK1161","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0348784397.USD","LU0348767384.USD","09926","LU0634319403.HKD","LU0561508036.HKD","LU0417516902.SGD","LU1720050803.USD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997273","title":"Akeso - China Nmpa Approves Ivonescimab Plus Chemotherapy for First-Line Advanced Squamous Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997273?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:18","pubTimestamp":1786537113,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN44916C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0348767384.USD","LU0348783233.USD","IE00B543WZ88.USD","LU2778985437.USD","LU0540923850.HKD","LU2476274308.USD","IE00BPRC5H50.USD","LU0348735423.USD","LU1961090484.USD","KURE","LU0561508036.HKD","LU1794554557.SGD","LU0634319403.HKD","09926","LU1720050803.USD","LU2476274720.SGD","LU0348827113.USD","LU0417516571.SGD","IE00B5MMRT66.SGD","LU2488822045.USD","LU0417516902.SGD","LU0348766576.USD","LU2399975544.HKD","LU0348784397.USD","BK1161","LU0348825331.USD","LU0417516738.SGD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658914838","title":"Akeso (SEHK:9926) Could Be 41% Undervalued On Phase II Breast Cancer Trial Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2658914838","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658914838?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:28","pubTimestamp":1786451296,"startTime":"0","endTime":"0","summary":"Akeso (SEHK:9926) has just reached a fresh clinical milestone. The company has dosed the first patient in a Phase II trial of its TROP2/Nectin-4 ADC AK146D1 in combination with ivonescimab for advanced breast cancer.\nSee our latest analysis for Akeso.\nAkeso's latest trial update comes after a mixed period for the stock, with a 7 day share price return of 8.58% and a 30 day share price return of 4.78%, but a 90 day share price return that declined 19.95%. Over longer horizons, total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-41-undervalued-on-phase-ii-breast-ca","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-41-undervalued-on-phase-ii-breast-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2476274308.USD","LU0348783233.USD","BK4097","BK1574","LU1961090484.USD","LU2778985437.USD","LU0417516902.SGD","LU0417516571.SGD","LU0348766576.USD","LU0348767384.USD","LU1794554557.SGD","LU0540923850.HKD","PRGS","LU2065732104.USD","BK1161","LU1720050803.USD","LU0348825331.USD","09926","KURE","IE00B5MMRT66.SGD","LU2476274720.SGD","LU0348827113.USD","LU0561508036.HKD","LU0634319403.HKD","LU0348735423.USD","IE00BPRC5H50.USD","LU0348784397.USD","LU2488822045.USD","LU2399975544.HKD","IE00B543WZ88.USD","LU0417516738.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126559610","title":"HK Movers | Hong Kong Biotech Stocks Rally; Genscript Bio Jumps Over 7%, Zai Lab Gains Over 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126559610","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126559610?lang=en_us&edition=fundamental","pubTime":"2026-08-11 10:08","pubTimestamp":1786414108,"startTime":"0","endTime":"0","summary":"Hong Kong-listed biotech stocks broadly rise, with $GENSCRIPT BIO(01548)$ up more than 7%, $ZAI LAB(09688)$ gaining over 6%, $BEONE MEDICINES(06160)$, $AKESO(09926)$, $WUXI BIO(02269)$ and $WUXI XDC(02268)$ rising more than 3%, and $WUXI APPTEC(02359)$ adding over 2%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926","09688","01548","06160","02268","02359","02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108118069","title":"Movement Alert｜AKESO Rises 3.15% in Regular Trading, Bispecific ADC Plus Ivonescimab Completes First Patient Dosing in Breast Cancer Phase II Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1108118069","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108118069?lang=en_us&edition=fundamental","pubTime":"2026-08-11 09:35","pubTimestamp":1786412111,"startTime":"0","endTime":"0","summary":"On August 11, AKESO rose 3.15% in regular trading, trading at 104.2 HKD/share, with turnover of approximately 45.92 million HKD.On the news front, the company announced that its Trop2/Nectin-4...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658602868","title":"Akeso Doses First Patient in Phase II Trial of Ak146d1 ADC Plus Ivonescimab in Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2658602868","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658602868?lang=en_us&edition=fundamental","pubTime":"2026-08-10 12:07","pubTimestamp":1786334823,"startTime":"0","endTime":"0","summary":"Akeso doses first patient in Phase II trial of AK146D1 ADC plus ivonescimab in advanced breast cancerAkeso dosed the first patient in a Phase II study of TROP2/Nectin-4 bispecific ADC AK146D1 combined","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDLc1w1yj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU0634319403.HKD","LU0348825331.USD","LU0348735423.USD","LU2488822045.USD","LU1794554557.SGD","IE00BPRC5H50.USD","LU0348767384.USD","LU1961090484.USD","LU0417516571.SGD","LU0417516738.SGD","LU2778985437.USD","LU0417516902.SGD","LU0561508036.HKD","LU0540923850.HKD","LU2476274720.SGD","IE00B543WZ88.USD","LU0348784397.USD","LU0348766576.USD","BK1161","LU1720050803.USD","LU2399975544.HKD","BK1574","KURE","LU0348783233.USD","LU2476274308.USD","09926","LU0348827113.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658460283","title":"Akeso Advances IO2.0 + Adc2.0 Strategy: First Patient Dosed in Phase Ii Study of Trop2/Nectin-4 Bispecific ADC (Ak146d1) Combined with Ivonescimab in Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2658460283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658460283?lang=en_us&edition=fundamental","pubTime":"2026-08-10 12:06","pubTimestamp":1786334787,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA5SMJJP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","LU1720050803.USD","LU0348783233.USD","LU0348825331.USD","LU0417516738.SGD","LU2778985437.USD","LU2399975544.HKD","LU0417516902.SGD","LU0348784397.USD","LU0417516571.SGD","LU1961090484.USD","LU0634319403.HKD","09926","IE00BPRC5H50.USD","BK1161","LU0348735423.USD","LU0540923850.HKD","IE00B5MMRT66.SGD","LU0348767384.USD","LU2476274720.SGD","LU2476274308.USD","BK1574","LU0348766576.USD","IE00B543WZ88.USD","KURE","LU0348827113.USD","LU1794554557.SGD","LU0561508036.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110466648","title":"HK Movers | Pharma Stocks Jump With Viva Biotech up 15%, WuXi XDC, WuXi Biologics up 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1110466648","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110466648?lang=en_us&edition=fundamental","pubTime":"2026-08-10 09:57","pubTimestamp":1786327069,"startTime":"0","endTime":"0","summary":"Pharma stocks jumped in Hong Kong. $Viva Biotech(01873)$ rose 15%; $WuXi XDC(02268)$ and $WuXi Biologics(02269)$ rose 6%; $WuXi AppTec(02359)$, $Zai Lab(09688)$, $JOINN(06127)$, $Genscript Biotech(01548)$, and $Akeso(09926)$ rose 5%.  ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548","02359","01873","06127","02268","09688","09926","02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123637493","title":"Movement Alert｜AKESO Rises 4% in Regular Trading, Multiple International Registrational Clinical Studies Advancing Rapidly","url":"https://stock-news.laohu8.com/highlight/detail?id=1123637493","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123637493?lang=en_us&edition=fundamental","pubTime":"2026-08-10 09:35","pubTimestamp":1786325750,"startTime":"0","endTime":"0","summary":"On August 10, AKESO rose 4% in regular trading, trading at 102.6 HKD/share, with turnover of 98.30 million HKD.On the news front, the company is seeing intensive clinical pipeline progress. Overseas...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}